Atrium Therapeutics Inc has recorded no insider trading activity within the previous ninety days. Consequently, there are no recent transactions to report regarding company shares held by corporate officers or directors. The firm last disclosed its results financiers on May 14, 2026, with the next scheduled update occurring in August.